In response to the down scheduling of prolonged-release melatonin to Pharmacist-Only for the management of primary insomnia in people aged 55 years and over, which came into effect on 1 June 2021, Guild Learning and Development has partnered with Aspen Australia to develop a new online course to assist pharmacists in navigating this new area.
The course titled, ‘Melatonin for the management of insomnia’, aims to educate pharmacists on the science of sleep, the role of melatonin, and when to recommend melatonin to patients as pharmacists will now have a greater role to play in providing information and support to patients with insomnia, including the supply of melatonin in line with the TGA decision.
To enrol in this course, visit: guilded.guild.org.au.
For more information, please contact Guild Learning and Development on 1800 049 056 or email learninganddevelopment@guild.org.au.
This activity has been accredited for one hour of Group 1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to one hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities.
